PIRAMAL CRITICAL CARE, INC.
BETHLEHEM, PA

Piramal Critical Care (PCC) is a prominent business unit of Piramal Pharma, known as the third-largest producer of inhaled anesthetics and a significant player in hospital generics globally. Established under the mission 'Save lives with critical care solutions,' PCC emphasizes delivering essential care to patients and healthcare providers worldwide while ensuring sustainable and profitable growth for all stakeholders. Headquartered in Bethlehem, Pennsylvania, PCC extends its operations across the US, Europe, and over 100 countries. The company has expanded its product portfolio to include inhalation anesthetics such as Sevoflurane, Isoflurane, Halothane; injectable pain and anesthesia drugs like Alfentanil, Fentanyl, Sufentanil, and Etomidate; treatments for spasticity via Intrathecal Baclofen (Gablofen); and plasma volume expanders such as Polygeline. These products are supported by top-tier manufacturing facilities in the US and India that meet stringent standards set by regulators including the US FDA and UK MHRA. PCC's history features strategic acquisitions from 2002 onwards, beginning with ICI India Ltd., to bolster its global presence in inhalation anesthetics, injectables for anesthesia and pain management, and more. Piramal Glass, partnered for glass packaging, reinforces PCC’s commitment to high-quality product delivery. A vital component of the Piramal Group—a diversified conglomerate active in sectors like healthcare, life sciences, financial services, and real estate—PCC benefits from a philosophy deeply rooted in corporate responsibility and empowerment. The Piramal Foundation further extends the group's impact through global philanthropic efforts in healthcare, education, and youth empowerment. Guided by values empowering decisive action and creating value, PCC thrives with a skilled workforce of over 400 employees worldwide, driven by entrepreneurship and a commitment to societal impact. As part of their organizational leadership, Mike Teague, Vice President of Supply Chain at Piramal Critical Care, has notably contributed to the company’s operational effectiveness since his pivotal role in transforming an acquired manufacturing site into a flagship operation post-2009 acquisition.